CAV1 and familial pancreatic carcinoma: CM from sh-Cav-1 PSCs exhibited upregulated levels of shh, MMP2, bFGF, and IL-6, which exert proliferative, invasive, angiogenic, and inflammatory functions during pancreatic cancer progression (Figure 2(a)).